Product Information
MINIVELLE 0.05 MG PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $11.5874 per EA under NDC 68968665008. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 29, 2012. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.05 mg/d
Manufacturer
Noven Therapeutics, LLCNDC
68968665008
Classification
Brand
Dosage Form
FILM, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOLApproval Type
New Drug (NDA)
FDA Application
NDA203752FDA Approved
10/29/2012
TE Code
AB3
On Market Since
12/20/2012
Pharmacological Classes
Price Statistics
The NADAC for MINIVELLE 0.05 MG PATCH has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5874 per EA |
|---|---|
| All-time high | $27.8278 (May 15, 2024) |
| All-time low | $8.4437 (Nov 28, 2013) |
| 52-week high | $11.5959 |
| 52-week low | $11.5811 |
| Median price | $21.7408 |
| Average price | $19.7517 |
| Largest weekly change | -58.3% (Apr 2, 2025) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINIVELLE 0.05 MG PATCH?
The current National Average Drug Acquisition Cost (NADAC) for MINIVELLE 0.05 MG PATCH, manufactured by Noven Therapeutics, LLC, is $11.5874 per EA (NDC 68968665008), effective Sep 30, 2026.
How has the price of MINIVELLE 0.05 MG PATCH changed over time?
Over the history we have for it, the NADAC for MINIVELLE 0.05 MG PATCH has risen 37.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MINIVELLE 0.05 MG PATCH?
Since Nov 28, 2013, the NADAC for MINIVELLE 0.05 MG PATCH has ranged from a low of $8.4437 (Nov 28, 2013) to a high of $27.8278 (May 15, 2024), with a median of $21.7408 per EA.
Are there cheaper alternatives to MINIVELLE 0.05 MG PATCH?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESTRADIOL 0.05 MG PATCH (2/WK), is $8.5036 per EA — about 27% below MINIVELLE 0.05 MG PATCH.
Who manufactures MINIVELLE 0.05 MG PATCH?
MINIVELLE 0.05 MG PATCH (NDC 68968665008) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.